Decapeptyl 22.5mg Vial POM x1

Powder and solvent for suspension for injection, sustained release formulation. Powder: White to off-white powder. Solvent: Clear solution.

Therapeutic indications
• Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration.
• Treatment of metastatic prostate cancer.
• As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
• As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
• As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.
• Treatment of central precocious puberty (CPP) in children 2 years and older with an onset of CPP before 8 years in girls and 10 years in boys).

Features

Nature and contents of container
• 6 mL septum vial with bromobutyl stopper and aluminium flip-off cap.
• Ampoule containing 2 mL of sterile solvent for suspension.

Special precautions for storage
• Do not store above 25°C. Keep the container in the outer carton. The reconstituted suspension for injection should be used immediately.

Shelf life
• The product should be used immediately after reconstitution.

Patient Information Leaflet
https://www.medicines.org.uk/emc/files/pil.5906.pdf